# De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learning

arXiv: https://arxiv.org/abs/2205.10473 · HTML: https://mlsanity.com/paper/2205.10473/

## Key facts

- Cited by 4 papers in the map (data through 14 Oct 2026).
- Builds on 11 of its 28 references that are in the map.
- First posted on arXiv 21 May 2022.

## Builds on (most cited first, 11 of 11)

- [Junction Tree Variational Autoencoder for Molecular Graph Generation](https://mlsanity.com/paper/1802.04364/) (2018)
- [SchNet: A continuous-filter convolutional neural network for modeling quantum interactions](https://mlsanity.com/paper/1706.08566/) (2017)
- [Graph Convolutional Policy Network for Goal-Directed Molecular Graph Generation](https://mlsanity.com/paper/1806.02473/) (2018)
- [Constrained Graph Variational Autoencoders for Molecule Design](https://mlsanity.com/paper/1805.09076/) (2018)
- [Deep Reinforcement Learning for De-Novo Drug Design](https://mlsanity.com/paper/1711.10907/) (2017)
- [Multi-Objective De Novo Drug Design with Conditional Graph Generative Model](https://mlsanity.com/paper/1801.07299/) (2018)
- [Molecular generative model based on conditional variational autoencoder for de novo molecular design](https://mlsanity.com/paper/1806.05805/) (2018)
- [Decoding the Protein-ligand Interactions Using Parallel Graph Neural Networks](https://mlsanity.com/paper/2111.15144/) (2021)
- [CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models](https://mlsanity.com/paper/2004.01215/) (2020)
- [DeepPurpose: a Deep Learning Library for Drug-Target Interaction Prediction](https://mlsanity.com/paper/2004.08919/) (2020)
- [PaccMannRL on SARS-CoV-2: Designing antiviral candidates with conditional generative models](https://mlsanity.com/paper/2005.13285/) (2020)

## Built on by (most cited first, 4 of 4)

- [CACTUS: Chemistry Agent Connecting Tool-Usage to Science](https://mlsanity.com/paper/2405.00972/) (2024)
- [Computer-Aided Multi-Objective Optimization in Small Molecule Discovery](https://mlsanity.com/paper/2210.07209/) (2022)
- [Challenges and Opportunities in Deep Reinforcement Learning with Graph Neural Networks: A Comprehensive review of Algorithms and Applications](https://mlsanity.com/paper/2206.07922/) (2022)
- [Structure-based drug discovery with deep learning](https://mlsanity.com/paper/2212.13295/) (2022)

## Abstract (arXiv)

Efficient design and discovery of target-driven molecules is a critical step in facilitating lead optimization in drug discovery. Current approaches to develop molecules for a target protein are intuition-driven, hampered by slow iterative design-test cycles due to computational challenges in utilizing 3D structural data, and ultimately limited by the expertise of the chemist - leading to bottlenecks in molecular design. In this contribution, we propose a novel framework, called 3D-MolGNNRL, coupling reinforcement learning (RL) to a deep generative model based on 3D-Scaffold to generate target candidates specific to a protein building up atom by atom from the starting core scaffold. 3D-MolGNNRL provides an efficient way to optimize key features by multi-objective reward function within a protein pocket using parallel graph neural network models. The agent learns to build molecules in 3D space while optimizing the activity, binding affinity, potency, and synthetic accessibility of the candidates generated for infectious disease protein targets. Our approach can serve as an interpretable artificial intelligence (AI) tool for lead optimization with optimized activity, potency, and biophysical properties.
